Black panthers
blm
pro Latino
pro Asians
but NO PRO WHITE..... Hmmmm
BEWARE...SOME DAYS ARE NOT VERY PRETTY. I GET CRABBY LIKE NORMAL PEOPLE DO. AND I DO SPEAK MY MIND. DO NOT READ IF YOU ARE SENSITIVE TO TRUE, REAL, EVERYDAY FEELINGS LIKE MINE.(But I think you would enjoy it) DON'T FORGET...FREEDOM OF SPEECH !
Black panthers
blm
pro Latino
pro Asians
but NO PRO WHITE..... Hmmmm
https://www.thegatewaypundit.com/2021/05/armed-black-supremacists-tulsa-will-come-time-will-kill-everything-white-sight-video/
PASS THIS ON
====================================================
Black activists from the New Black Panther Party and other groups staged an armed march in Tulsa, Oklahoma on Saturday.
Organizers held a Second Amendment “March for Reparations” and marched through downtown Tulsa.
“The struggle for Reparations must be escalated,” a news release from organizers read. “We must fight on every front to achieve redress and Reparations for the atrocities committed upon Tulsa Massacre descendants; and we must intensify the fight to achieve Reparations for all 40-million Blacks still grossly affected by racism, inequality, wealth disparity, police brutality and the like. Tulsa will mark a new beginning in the upgraded fight for Reparations for Black people.”
Activists shouted, “Black power! Black power!”
Another supremacist threatened white people and said, “Because that time will come when there’s a rat-a-tat-tat… black Americans will kill everything white in sight.”
The following groups participated in Saturday’s march:
Meanwhile, the FBI is busy hunting down grandmas who aimlessly wandered through the Capitol on January 6.
Really????
Why ??? What happened to it... where did it go?....
So there were NO deaths from the flu last year (flu season)?
Hmmm
What the hell are people putting in their bodies???
how many of you gave her your hard earned money so she could buy her THREE MILLION DOLLAR homes etc?
A Black Lives Matter co-founder has resigned from her role as executive director amid controversy over her $3m property portfolio.
Patrisse Cullors, who founded the racial justice movement in 2013, is a self-described “Marxist” but faced criticism after it was reported last month that she owns four properties, including a $1.4m house in Malibu and a ranch in Georgia.
The 37-year-old says she was the victim of “right-wing attacks that tried to discredit my character,” and that her resignation had long been planned because she has a new book and television deal.
"I've created the infrastructure and the support, and the necessary bones and foundation, so that I can leave," she said.
"It feels like the time is right.
“I don’t operate off of what the right thinks about me,” she added as she denied that finances had any relation to her resignation.
BLM said she had "received a total of $120,000 since the organisation's inception” following the 2013 acquittal of George Zimmerman, the neighborhood watch volunteer who killed 17-year-old Trayvon Martin in Florida.
This was for duties such as serving as spokesperson and engaging in political education work.
Claims that she had misused donations to purchase property were strongly denied and last month she told the Black News Channel that suggestions of financial impropriety against her were "categorically untrue and incredibly dangerous".
But she faced criticism from BLM organisers over the way she has spent her money.
“If you go around calling yourself a socialist, you have to ask how much of her own personal money is going to charitable causes,” Hawk Newsome, a Black Lives Matter organiser, told The New York Post.
"It's really sad because it makes people doubt the validity of the movement."
BLM collected $90 million in donations last year, as the movement hit the global spotlight following the murder of George Floyd by police officer Derek Chauvin, in Minneapolis.
The foundation spent a third of that sum in 2020 on operating expenses, grants to black-led organisations and other charitable giving.
But concerns have been raised as to how much of the funding was spent on racial justice programmes.
Activists called for more transparency and said more should be given to the black communities directly impacted by police brutality.
“That is the most tragic aspect,” said the Rev T Sheri Dickerson, the president of an Oklahoma City BLM chapter and a representative of the BLM10, a national group of organisers that has publicly criticised the foundation over funding and transparency.
“I know some of [the families] are feeling exploited, their pain exploited, and that’s not something that I ever want to be affiliated with.”
Ms Cullors and the foundation said that they support families without disclosing finances or making public announcements.
In 2018, Ms Cullors’ book "When They Call You a Terrorist: A Black Lives Matter Memoir” became a New York Times bestseller.
She will release a second book, "An Abolitionists Handbook”, in October and has a multi-year deal with Warner Bros to produce original content centred on black stories.
The first of her TV projects will debut in July, she said.
"I think I will probably be less visible, because I won't be at the helm of one of the largest, most controversial organisations right now in the history of our movement," Ms Cullors said.
"I'm aware that I'm a leader, and I don't shy away from that. But no movement is one leader."
As she departs, the foundation is bringing aboard two new interim senior executives to help steer it in the immediate future: Monifa Bandele, a longtime BLM organiser and founder of the Malcolm X Grassroots Movement in New York City, and Makani Themba, an early backer of the BLM movement and chief strategist at Higher Ground Change Strategies in Jackson, Mississippi.
"I think both of them come with not only a wealth of movement experience, but also a wealth of executive experience," Ms Cullors said.
It looks like Americans may need to roll up their sleeves for a COVID-19 booster shot, though vaccine makers and federal officials are still trying to detect how long immunity to the virus lasts.
In the latest race to the regulatory finish line, Pfizer Inc. PFE, 0.30% is testing its experimental COVID-19 booster shot in combination with its 20-valent pneumococcal conjugate vaccine in older adults, while Moderna Inc. MRNA, 3.16% told investors this month that a mid-stage clinical trial showed its investigational booster can help protect against the serious B.1.351 and P.1. variants.
Moderna and Pfizer both developed two-dose, mRNA vaccines with similar rates of real-world effectiveness.
The COVID-19 vaccines developed by these companies, as well as the Johnson & Johnson JNJ, 0.44% shot — the third vaccine to be authorized in the U.S. — are all considered very effective, especially when it comes to preventing hospitalization and death, but it’s still unknown how long they can protect people against the virus.
See also: Booster dose of COVID vaccines to be given to U.K. volunteers in new trial
“We do not have data on when to expect waning immunity leading to breakthrough infections,” Dr. Stephen Hoge, Moderna’s president, told investors, according to a FactSet transcript of a May 6 earnings call. “But we do know that there is a raging pandemic, that reinfections will happen at some point, and the best way to ensure that we do not have renewed outbreaks in well-vaccinated countries is to boost and maintain the highest possible levels of neutralizing antibodies.”
Moderna and Pfizer have recently said immunity can start to wane between six to eight months after getting the second shot of their vaccines. Dr. Peter Marks, a Food and Drug Administration official, estimates that vaccine-induced immunity is around one year, according to public remarks reported by CNBC.
“I would project that it’s actually going to be longer than that,” Dr. Mark Mulligan, director of NYU Langone Health’s Vaccine Center, said in a May 3 interview. “It might be a year or even more. But in all likelihood, for boosting of the magnitude of the antibody levels and other immune responses, boosters will be needed.”
If SARS-CoV-2 becomes an endemic virus, as some medical experts have predicted, boosters are one way to keep people protected and also address gaps in immunity caused by powerful variants like B.1.351, first detected in South Africa, and the P.1 first identified in Brazil that are thought to lessen the effectiveness of these vaccines.
However, at this point, it’s all speculation. There is no medical consensus about whether booster shots are necessary to ensure continued protection against this virus or even what the durability of immunity to this virus is.
“There’s absolutely no evidence that we need a booster shot of anything,” Dr. Carlos del Rio, an infectious-disease physician and executive associate dean of the Emory University School of Medicine, said April 28. “The most important thing to do is to get vaccinated right now. Whether you’re going to need a booster shot, we’ll worry about that later.”
The case for-or-against booster shots
The only data about the length of vaccine-induced immunity, which likely takes into account antibody titer levels and T-cell response, is limited at this time.
“We do not know precisely when we will need to boost,” Dr. Anthony Fauci, President Joe Biden’s chief medical advisor, said Tuesday during a White House briefing.
One study found that the Pfizer vaccine, which was developed with BioNTech SE BNTX, 3.00%, has a 91.3% efficacy rate among clinical-trial participants six months after they got the second dose. Other research indicates that people who are enrolled in the Phase 1 clinical study for Moderna’s vaccine still had antibodies six months after getting the second shot.
“It’s likely that it’s not just a single booster but that this would be a repeated event over the next several years,” Mulligan said. “If we achieve broad enough vaccination to shut down virus transmission and have the pandemic die out, great. But we’re so far [from] that right now.”
About 39% of people in the U.S. are fully vaccinated, as of Tuesday, according to the latest data from the Centers for Disease Control and Prevention, though vaccination rates in the U.S. have been slowing for weeks.
Other experts disagree with the push for boosters, citing a lack of data.
Cornell University virologist John Moore recently told Axios “it’s not proven that we need boosters yet. Whereas it’s appropriate to plan for boosters, you’ve got to look at whether there’s a corporate agenda behind this.”
Del Rio instead predicts a future in which the U.S. will have the virus under control, and Americans may need a COVID-19 booster to travel to certain countries, much like how a yellow fever vaccine or booster is recommended or required for travel to certain Central and South American and African countries.
“I suspect that if there’s a variant in India, and you decide to travel to India, you will be told, as part of your travel, you’re going to have to take this,” he said.
Are boosters another billion-dollar opportunity for vaccine makers?
COVID-19 vaccines are already a booming business for drug makers, and boosters are part of the corporate strategy going forward. (Moderna executives mentioned their booster shot dozens of times on their most recent earnings call.)
Pfizer and BioNTech expect their vaccine to generate $26 billion in revenue this year, while Moderna just reported its first-ever billion-dollar sales quarter.
While the U.S. government has not announced any purchases of COVID-19 booster shots, other countries have. Australia, Israel, and Switzerland have already inked deals with these drug makers to buy millions of booster doses for 2022.
Pfizer anticipates it will get data for its booster candidate in July, with plans to file for authorization that same month and then get a regulatory okay in the U.S. sometime in 2021.
The company is developing two types of shots: one functions like a third dose of its currently available vaccine, aiming to boost immunity among participants from its Phase 1 clinical trial in the U.S., and the other uses a modified mRNA sequence. It announced the booster/pneumococcal conjugate vaccine study this week.
Moderna is testing three types of boosters:
What about other vaccine makers?
J&J has not yet shared any longer-term data about its vaccine’s immune response, though executives have noted that the company plans to assess whether there is a need to develop a booster.
However, some Wall Street analysts have said it’s easier to develop boosters for mRNA and protein-based vaccines than adenovirus-based vaccines like the J&J shot. (Novavax Inc. NVAX, -2.03% is an example of a company developing a protein-based COVID-19 vaccine candidate.)
Sanofi SNY, 0.96%, which has previously reported some delays moving its COVID-19 vaccine through development, recently hinted to investors that its still-investigational single-dose COVID-19 shot may have more value as a booster. The vaccine candidate is expected to move into Phase 3 clinical trials, and it will also be tested in a booster-specific study.
That said, boosters and vaccination in general doesn’t need to be a one-size-fits-all model for every single person.
The U.S. could test out a different approach for booster shots that evaluates an individual’s antibody levels to assess whether or not they need a booster shot at all, said Dr. Michael Mina, an assistant professor of epidemiology at the Harvard T.H. Chan School of Public Health. This is because immunity shows up differently in different people, based on factors like age and overall health.
“It would be super easy to set up, and it could be voluntary,” Mina said. “Do you want a booster? Do you want to see if you need a booster? To get there, we would really want to start building correlates of protection, meaning: what is the antibody level that we feel good as a physician or as a public health agency saying, if you’re at this level, you’re probably still protected.”
American soldiers have mistakenly revealed the exact locations of US nuclear weapons in Europe by uploading details as part of revision exercises that were publicly available to view, a report claims.
An investigation by Bellingcat alleges that soldiers attempting to learn intricate security protocols uploaded a multitude of sensitive information to the internet, including not only the bases at which the weapons are held, but in which exact vaults they are stored.
The US Air Force has launched an investigation into "the suitability of information shared via study flashcards."
Questions and answers were written on flashcards, which have now disappeared, and appeared to show the positions of cameras, the frequency of patrols around the vaults, secret duress words that signal when a guard is being threatened and the unique identifiers that a restricted area badge needs to have, Bellingcat said.
The cards had been uploaded as long ago as 2013 on websites including Cram, Quizlet and Chegg, and accessed as recently as April this year. Some of those sites have the visibility of the cards set to be viewed by anyone by default.
The presence of US nuclear weapons in Europe acted as a deterrent to the Soviet Union during the Cold War and also meant European countries would not need to develop their own.
Various leaked documents have indicated that they use six sites across the continent.
In 2019, a document, written for the Defence and Security Committee of the Nato Parliamentary Assembly, made passing reference to the roughly 150 US nuclear weapons being stored in Europe.
“These bombs are stored at six US and European bases - Kleine Brogel in Belgium, Büchel in Germany, Aviano and Ghedi-Torre in Italy, Volkel in The Netherlands, and Incirlik in Turkey,” one line read, according to the Belgian newspaper De Morgen.
The Bellingcat report features screenshots of flashcards indicating that soldiers are taught what to shout to an intruder in the local language.
One card relating to the 701st Munitions Maintenance Squadron shows a phrase to make someone surrender weapons in Flemish, indicating that the security details in it apply to Kleine Brogel air base, Belgium.
The most revealing information, however, pertained to a “vault status” flashcard that appeared to note which shelters at Volkel contain nuclear weapons.
Five were listed as “hot” and six as “cold.”
To further corroborate their story, Bellingcat unearthed a photograph on Facebook posted by someone associated with 703rd MUNSS.
It is a large group photo showing more than 50 individuals wearing US military uniforms posing beside a Dutch army vehicle and in front of a nuclear warhead.
Using geolocating technology and a leaked map of the site, it appears that the soldiers are standing in front of vault 532 - which on the flashcard, is listed as “cold.”
Dr Jeffrey Lewis, Director of the East Asia Nonproliferation Program at the James Martin Centre for Nonproliferation Studies said it would be highly unlikely for active service members to pose with a live bomb.
Dr Lewis said that the flashcard information about the vault being “cold” is likely to be correct.
The information disclosure is a “flagrant breach” of security practices, he told Bellingcat.
“This is yet one more warning that these weapons are not secure.”
The Dutch ministry of Defence told Bellingcat: “This photo should not have been taken, let alone published.”
Hans Kristenssen, director of the Nuclear Information Project at the Federation of American Scientists, said: “There are so many fingerprints that give away where the nuclear weapons are that it serves no military or safety purpose to try to keep it secret. Safety is accomplished by effective security, not secrecy.”
But some of the details which soldiers were trying to learn included how to authenticate security badges.
In one screenshot, a flashcard detailed that ‘VOLKEL’ should be spelt without the first L and that ‘MUNSS’ should be missing an S.
Another card allegedly details where the emblems and flags should appear on the security pass.
A US Air Force Spokesperson told the Telegraph: “The Department of the Air Force is investigating the suitability of information shared via study flashcards."